early diagnosis of diabetic nephropathy
TRANSCRIPT
![Page 1: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/1.jpg)
EARLY DIAGNOSIS OF DIABETIC
NEPHROPATHY
Dr. Nabieh Al-HilaliConsultant Physician and Nephrologist
Member of ERA-EDTA and ISNMedicare Middle East
![Page 2: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/2.jpg)
OBJECTIVES To discuss the risk of development of
Diabetic nephropathy
To discuss pros and cons of Microalbuminuria
Is there any Novel biomarkers for early detection of diabetic nephropathy?
![Page 3: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/3.jpg)
DIABETIC N BACKGROUND
![Page 4: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/4.jpg)
BACKGROUND More than 387 million people are currently
suffering from diabetes. The International Diabetes Federation
estimated that this would rise to 592 million within a generation.
Egypt is one of the 20 countries of the IDF.
There were over 7.5 million cases of diabetes in Egypt in 2014.
![Page 5: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/5.jpg)
MENA More than 37
million people in the MENA
By 2035 this will rise to 68 million.
![Page 6: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/6.jpg)
![Page 7: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/7.jpg)
PREVALENCE OF DIABETES IN EGYPT 2014
![Page 8: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/8.jpg)
DIABETIC NEPHROPATHY
![Page 9: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/9.jpg)
DIABETIC NEPHROPATHY Diabetic nephropathy is a clinical syndrome characterized by the following: Persistent albuminuria (>300 mg/d or
>200 μg/min) that is confirmed on at least 2 occasions 3-6 months apart
Progressive decline in the GFR Elevated arterial blood pressure In the 1930s, Kimmelstiel and Wilson
described the classic lesions of nodular glomerulosclerosis in diabetes associated with proteinuria and hypertension.
![Page 10: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/10.jpg)
NATURAL HISTORY OF DIABETIC NEPHROPATHYDiabetic Nephropathy progresses through
five predictable stages which are as follows:-
Stage 1 (very early diabetes ) Above-normal GFR.(>90ml/min ) with
enlarged kidneysHyperglycemia leads to hyperfiltration
due to osmotic load and to toxic effects of high sugar on kidney cells
![Page 11: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/11.jpg)
NATURAL HISTORY OF DIABETIC NEPHROPATHY(CONTD.) Stage 2 (developing) Silent phase with *Continued hyperfiltration and hypertrophy *The GFR remains elevated or has returned
to normal ( GFR 60-89ml/min )
*Glomerular damage has progressed to significant microalbuminuria
![Page 12: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/12.jpg)
NATURAL HISTORY OF DIABETIC NEPHROPATHY (CONTD.)Stage 3 (overt, or dipstick-positive)
Glomerular damage has progressed to clinical albuminuria more than 300 mg /day
GFR 30-59ml/min .
Basement membrane thickening
Hypertension typically develops during stage 3.
![Page 13: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/13.jpg)
NATURAL HISTORY OF DIABETIC NEPHROPATHY (CONTD.)Stage 4 (late-stage) Glomerular damage continues, with increasing
amounts of protein albumin in the urine. The kidneys’ filtering ability has begun to decline
steadily, and blood urea nitrogen (BUN) and creatinine (Cr) has begun to increase.
The glomerular filtration rate (GFR) decreases further more with ( GFR 15-29ml/min ).
Almost all patients have hypertension at stage 4.
![Page 14: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/14.jpg)
NATURAL HISTORY OF DIABETIC NEPHROPATHY (CONTD.)Stage 5 (ESRD) GFR has fallen to <15 ml/min and renal
replacement therapy (i.e., haemodialysis, peritoneal dialysis, kidney transplantation) is needed.
![Page 15: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/15.jpg)
DIABETIC NEPHROPATHY
Currently, DN is the leading cause of chronic kidney disease in the United States and other Western societies.
Diabetes is responsible for 30-40% of all ESRD) cases in the United States
Studies among Arabs showed that about half of the ESRD in different dialysis modalities are diabetic.
Alhilali N. et al in 2003 and 2007
![Page 16: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/16.jpg)
RISK FACTORS OF DIABETIC NEPHROPATHY Genetic Factors Inadequate Glucose Control High blood pressure Hyperlipidemia Smoking Long Standing Diabetes Pregnancy Poor nutrition during pregnancy Overweight Unhealthy diet Physical inactivity Ethnicity
![Page 17: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/17.jpg)
DIABETIC N PREVENTIONDETECTION
![Page 18: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/18.jpg)
PREVENTION OF DIABETIC NEPHROPATHY Good evidence suggests that early
treatment delays or prevents the onset of diabetic nephropathy .
Regular outpatient follow-up is key in managing diabetic nephropathy successfully.
![Page 19: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/19.jpg)
EARLY DETECTION OF DIABETIC NEPHROPATHY Recently, attention has been called to
atypical presentations of diabetic nephropathy with dissociation of proteinuria from reduced kidney function.
Also noted is that microalbuminuria is not always predictive of diabetic nephropathy.
![Page 20: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/20.jpg)
DIABETIC N BIOMARKERS
![Page 21: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/21.jpg)
WHAT IS BIOMARKER ? Biomarker: A biologic element that can be
used to measure the presence of disease progress of disease the effects of treatment.
![Page 22: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/22.jpg)
![Page 23: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/23.jpg)
Inflammation Renal injury
Diabetic Nephropathy Progression
Warning albuminureaDecline in GFR
BiomarkersSoluble TNF receptors 1 and 2
FGF23FABPs
PEDF
FGF21
FABPs = Fatty acid binding proteins; FGF =Fibroblast growth factor; GFR = glomerular filtration rate;PEDF = Pigment epithelium-derived factor; TNF = Tumor necrosis factor;
![Page 24: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/24.jpg)
MICROALBUMINURIA In the past, persistent microalbuminuria was the
most studied biomarker in diabetic nephropathy. Both the presence and the incremental changes
in microalbuminuria had been shown to correlate with the development and progression of chronic kidney disease in diabetic patients.
Furthermore, microalbuminuria was also shown to be a risk factor for the development of macrovascular complications in diabetic patients.
![Page 25: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/25.jpg)
CHALLENGED OF MICROALBUMINURIA- 1/2 high variability,
low sensitivity and specificity in predicting kidney disease progression in diabetic nephropathy.
spontaneous remission of MA could occur in more than half of diabetic patients.
Furthermore, 20% of type 2 diabetic patients had their GFR decline to ≤60 mL/ min/1.73 m2 before or even without passing the stage of microalbuminuria.
Progression diabetic nephropathy is not necessarily parallel with progression of urinary albumin excretion.
![Page 26: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/26.jpg)
CHALLENGED OF MICROALBUMINURIA- 2/2 Only a minority of patients with MA progress to
proteinuria
one third of patients with MA, progressive renal function decline starts already at the onset of MA, not proteinuria.
.As a prognostic biomarker for progression of diabetic nephropathy, microalbuminuria fails in terms of sensitivity and specificity
Therefore these doubts about microalbminuria has promoted vigorous search for new markers
![Page 27: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/27.jpg)
NOVEL BIOMARKERS This has led to active research on new prognostic
biomarkers for progressive diabetic nephropathy in recent years.
Of the emerging candidate biomarkers, 1.Serum cystatin C 2.Markers of inflammation 3.Fatty acid binding proteins(FABP) 4.Pigment epithelium-derived factor (PEDF) 5. Fibroplast Growth Factor 21(FGF21) 6.Peptidome
have provided the most promising data.
![Page 28: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/28.jpg)
SERUM CYSTATIN C Serum cystatin C is produced by all nucleated cells,
freely filtered by the glomeruli
completely metabolized by the proximal renal tubules.
An observational study by Krolewski et al. showed that the measurement of serum cystatin C
improved the risk prediction of DN progression to ESRD in diabetic patients.
Subjects given a higher baseline CKD stage by cystatin C-based eGFR than by creatinine-based eGFR
![Page 29: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/29.jpg)
MARKERS OF INFLAMMATION
Inflammation is clearly one of the key players in the pathogenesis of diabetic nephropathy
It is also potential candidate for the prediction of progressive kidney disease in diabetes.
FGF23, an endocrine hormone (related to phosphate homeostasis and vitamin D activation),
Circulating TNF receptors (1 and 2), had been shown to predict renal outcome in DN.(Niewczas et al)
another study has shown the predictive effect of FGF23 on the risk of progression in diabetic nephropathy was dependent on the TNF receptor
These suggested the superiority of using serum TNF receptor 1 over conventional biomarkers, such as microalbuminuria
![Page 30: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/30.jpg)
FATTY ACID BINDING PROTEINS Recently, fatty acid binding proteins,(a
group of diverse proteins involved in lipid homeostasis), have also been reported as potential biomarkers for diabetic nephropathy.
Elevated urinary levels of liver-fatty acid binding protein (L-FABP) were detected in diabetic patients even before the onset of microalbuminuria.
![Page 31: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/31.jpg)
PEPTIDOME Composed of low molecular weight protein
and peptide fragment
Its presence correlate with early renal function decline in diabetes.
It reflect changes in both tubular and glomerular protein expression.
Thus, urine peptide expression may provide insight into renal pathophysiologic mechanisms.
![Page 32: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/32.jpg)
Bhensdadia et al Urinary haptoglobin as a potential
prognostic biomarker for progressive diabetic nephropathy was identfied.
Although as a single marker urinary haptoglobin adds little to albuminuria, together the two appear to provide better diagnostic accuracy than albuminuria alone.
![Page 33: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/33.jpg)
![Page 34: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/34.jpg)
CONCLUSIONS
![Page 35: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/35.jpg)
CONCLUSIONSTo conclude, As a prognostic biomarker for progression of diabetic
nephropathy, microalbuminuria fails in terms of sensitivity and specificity
There is clearly a need for novel biomarkers with high sensitivity and specificity for predicting the progression of diabetic nephropathy.
good biomarkers could also bring new insights into the pathogenesis of diabetic nephropathy, and open up new therapeutic options for preventing nephropathy progression.
it is anticipated that more biomarkers will continue to be discovered.
![Page 36: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/36.jpg)
![Page 37: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/37.jpg)
![Page 38: Early diagnosis of diabetic nephropathy](https://reader035.vdocuments.mx/reader035/viewer/2022081604/587a64671a28ab8a2a8b4ddb/html5/thumbnails/38.jpg)